| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |